Exploring QSARs for inhibitory activity of non-peptide HIV-1 protease inhibitors by GA-PLS and GA-SVM
- PMID: 20486937
- DOI: 10.1111/j.1747-0285.2010.00953.x
Exploring QSARs for inhibitory activity of non-peptide HIV-1 protease inhibitors by GA-PLS and GA-SVM
Abstract
The support vector machine (SVM) and partial least square (PLS) methods were used to develop quantitative structure activity relationship (QSAR) models to predict the inhibitory activity of non-peptide HIV-1 protease inhibitors. Genetic algorithm (GA) was employed to select variables that lead to the best-fitted models. A comparison between the obtained results using SVM with those of PLS revealed that the SVM model is much better than that of PLS. The root mean square errors of the training set and the test set for SVM model were calculated to be 0.2027, 0.2751, and the coefficients of determination (R(2)) are 0.9800, 0.9355 respectively. Furthermore, the obtained statistical parameter of leave-one-out cross-validation test (Q(2)) on SVM model was 0.9672, which proves the reliability of this model. The results suggest that TE2, Ui, GATS5e, Mor13e, ATS7m, Ss, Mor27e, and RDF035e are the main independent factors contributing to the inhibitory activities of the studied compounds.
Similar articles
-
Exploring QSARs for antiviral activity of 4-alkylamino-6-(2-hydroxyethyl)-2-methylthiopyrimidines by support vector machine.Chem Biol Drug Des. 2008 Sep;72(3):205-16. doi: 10.1111/j.1747-0285.2008.00695.x. Epub 2008 Aug 19. Chem Biol Drug Des. 2008. PMID: 18715229
-
Application of genetic algorithm-support vector machine (GA-SVM) for prediction of BK-channels activity.Eur J Med Chem. 2009 Dec;44(12):5023-8. doi: 10.1016/j.ejmech.2009.09.006. Epub 2009 Sep 12. Eur J Med Chem. 2009. PMID: 19837488
-
A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine.Bioorg Med Chem. 2007 Dec 15;15(24):7746-54. doi: 10.1016/j.bmc.2007.08.057. Epub 2007 Sep 1. Bioorg Med Chem. 2007. PMID: 17870538
-
3D QSAR in modern drug design.EXS. 2003;(93):223-41. doi: 10.1007/978-3-0348-7997-2_11. EXS. 2003. PMID: 12613179 Review. No abstract available.
-
Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM).Mol Divers. 2011 Feb;15(1):269-89. doi: 10.1007/s11030-010-9234-9. Epub 2010 Mar 20. Mol Divers. 2011. PMID: 20306130 Review.
Cited by
-
Sequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonism.PLoS One. 2014 Oct 16;9(10):e109340. doi: 10.1371/journal.pone.0109340. eCollection 2014. PLoS One. 2014. PMID: 25330207 Free PMC article.
-
A computational study on thiourea analogs as potent MK-2 inhibitors.Int J Mol Sci. 2012;13(6):7057-7079. doi: 10.3390/ijms13067057. Epub 2012 Jun 8. Int J Mol Sci. 2012. PMID: 22837679 Free PMC article.
-
HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors.J Cheminform. 2018 Mar 9;10(1):12. doi: 10.1186/s13321-018-0266-y. J Cheminform. 2018. PMID: 29524011 Free PMC article.
-
Nature is the best source of anti-inflammatory drugs: indexing natural products for their anti-inflammatory bioactivity.Inflamm Res. 2018 Jan;67(1):67-75. doi: 10.1007/s00011-017-1096-5. Epub 2017 Sep 27. Inflamm Res. 2018. PMID: 28956064
-
Quantitative Structure-Activity Relationship Model to Predict Antioxidant Effects of the Peptide Fraction Extracted from a Co-Culture System of Chlorella pyrenoidosa and Yarrowia lipolytica.Mar Drugs. 2019 Nov 8;17(11):633. doi: 10.3390/md17110633. Mar Drugs. 2019. PMID: 31717355 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources